CID 117797905

Glumetinib

Structural Information

Molecular Formula
C21H17N9O2S
SMILES
CN1C=C(C=N1)C2=CN3C(=NC=C3S(=O)(=O)N4C5=C(C=N4)N=CC(=C5)C6=CN(N=C6)C)C=C2
InChI
InChI=1S/C21H17N9O2S/c1-27-11-16(7-24-27)14-3-4-20-23-10-21(29(20)13-14)33(31,32)30-19-5-15(6-22-18(19)9-26-30)17-8-25-28(2)12-17/h3-13H,1-2H3
InChIKey
RYBLECYFLJXEJX-UHFFFAOYSA-N
Compound name
6-(1-methylpyrazol-4-yl)-1-[6-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]sulfonylpyrazolo[4,3-b]pyridine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

172
Patents

459.1226 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 460.12988 197.6
[M+Na]+ 482.11182 214.8
[M+NH4]+ 477.15642 202.2
[M+K]+ 498.08576 215.0
[M-H]- 458.11532 201.0
[M+Na-2H]- 480.09727 206.7
[M]+ 459.12205 201.6
[M]- 459.12315 201.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe